Press & Media

SkinMedica to Present at Cowen and Company 30th Annual Health Care Conference

CARLSBAD, CALIF. - March 5, 2010 - SkinMedica, Inc. today announced that the Company's President and CEO, Mary Fisher, will present at the Cowen and Company 30th Annual Health Care Conference on Tuesday, March 9, 2010, at 3:00pm ET at the Boston Marriott Copley Place in Boston, Massachusetts.

Contact:
Sarah McCabe
Stern Investor Relations
212-362-1200
sarah@sternir.com

###

About SkinMedica

SkinMedica, Inc. is focused on developing, acquiring, and commercializing products that improve the appearance of skin. SkinMedica markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum® and hallmark TNS Recovery Complex®. The formulations in SkinMedica’s clinical skin care collection enhance skin appearance, reduce signs of aging, and provide other skin care benefits. SkinMedica's primary prescription product, VANIQA® (eflornithine hydrochloride) Cream, 13.9%, is the only FDA-approved prescription product for the reduction of unwanted facial hair in women. SkinMedica is based in Carlsbad, California.

TNS Recovery Complex®, VANIQA®, EpiQuin® Micro, and SkinMedica®, are registered trademarks of SkinMedica, Inc and affiliates.